United Kingdom· GB-APID-33509411000001105
Alprolix 1,000unit powder and solvent for solution for injection vials
A eftrenonacog alfa product containing eftrenonacog alfa, registered in United Kingdom by Swedish Orphan Biovitrum Ltd. The same ATC class is registered in 3 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Eftrenonacog alfa is registered in 3 of 19 countries.
Countries holding a registration under ATC B02BD34 (eftrenonacog alfa), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 2 of them publish a price we can compare per daily dose
Eftrenonacog alfa · ATC B02BD34
3 / 19 countries
- Franceprice
- Italyprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Eftrenonacog alfa
- Manufacturer
- Swedish Orphan Biovitrum Ltd
- Country
- United Kingdom (GB)
- ATC code
- B02BD34
- ATC class
- Eftrenonacog alfa
- Defined daily dose
- 400 E, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin7350031441048
- gtin07350031443752
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eftrenonacog alfa in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- Japanエフトレノナコグ アルファ（遺伝子組換え）サノフィ
- SwitzerlandAlprolix
- CzechiaALPROLIXSwedish Orphan Biovitrum AB (publ), Stockholm
- SpainALPROLIX 1.000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLESwedish Orphan Biovitrum Ab (Publ)
- FinlandALPROLIXSwedish Orphan Biovitrum AB (publ)
- FranceALPROLIX 1000 UI, poudre et solvant pour solution injectableSWEDISH ORPHAN BIOVITRUM (SUEDE)
- SwedenALPROLIX 1000 IE Pulver och vätska till injektionsvätska, lösningSwedish Orphan Biovitrum AB (publ)
- PolandAlprolixSwedish Orphan Biovitrum AB
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Alprolix
- Liechtenstein · Alprolix
- Norway · Alprolix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1499a443-4d77-4189-bc35-aef05ae43a6c GET /v1/drugs/1499a443-4d77-4189-bc35-aef05ae43a6c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "33509411000001105",
"desc": "Alprolix 1,000unit powder and solvent for solution for injection vials (Swedish Orphan Biovitrum Ltd)",
"form": "Powder and solvent for solution for injection",
"vpid": "33509211000001106",
"source": "dmd",
"vtm_id": "33507711000001107",
"strength": "1000 unit",
"substance": "Eftrenonacog alfa",
"ingredient": "Eftrenonacog alfa",
"supplier_code": "4232111000001108"
}See everything about eftrenonacog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.